Oncoxin-Viusid

DIETARY_SUPPLEMENT2 trials

Sponsors

Catalysis SL

Conditions

Cutaneous Melanoma, Stage IICutaneous Melanoma, Stage IIIMalignant Cutaneous MelanomaProstate Cancer

Phase 2

Evaluation of Oncoxin-Viusid® in Cutaneous Melanoma

CompletedNCT03541148

Catalysis SLCutaneous Melanoma, Stage II, Cutaneous Melanoma, Stage III, Malignant Cutaneous Melanoma

Start: 2014-09-16End: 2018-04-13Updated: 2018-05-30

Evaluation of Oncoxin-Viusid® in Prostate Cancer

CompletedNCT03543670

Catalysis SLProstate Cancer

Start: 2017-09-16End: 2018-12-30Updated: 2019-05-22

Related Papers

Oncoxin‑Viusid<sup>&reg;</sup> may improve quality of life and survival in patients with hormone‑refractory prostate cancer undergoing onco‑specific treatments

Molecular and Clinical Oncology2020-11-059 citations